FDA official logo
GSRS logoPFDA official logo

LUTETIUM (177LU) ROFAPITIDE TETRAXETAN

UNII:T4GK6SP4E2
Type:INGREDIENT SUBSTANCE
Formula:C67H95N13O18S3.Lu.H
Preferred Substance Name:LUTETIUM (177LU) ROFAPITIDE TETRAXETAN
InChIKey:
YSYFTHWGZOTNAV-BSYBIPGTSA-K
GSRS Full Record:
T4GK6SP4E2
i

  • 2583700-68-7
  • (5R,11S,17S,20S,23S,26S,29R)-23-(3-amino-3-oxopropyl)-26-benzyl-5-(hexanoylamino)-20-[(1R)-1-hydroxyethyl]-6,12,18,21,24,27-hexaoxo-35-[2-[[2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetyl]amino]ethylsulfanylmethyl]-3,31-dithia-7,13,19,22,25,28-hexazatetracyclo[31.3.1.07,11.013,17]heptatriaconta-1(37),33,35-triene-29-carboxylate;hydron;lutetium-177(3+)
  • Lutetate(1-)-177Lu, [S-[[3-(mercaptomethyl)-5-[[[2-[[2-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN1,κN4,κN7,κN10]acetyl-κO]amino]ethyl]thio]methyl]phenyl]methyl]-N-(1-oxohexyl)-L-cysteinyl-L-prolyl-L-prolyl-L-threonyl-L-glutaminyl-L-phenylalanyl-L-cysteine cyclic (1→7)-thioetherato(4-)]-, hydrogen (1:1)
  • Lutetium (177Lu) rofapitide tetraxetan
  • [2,2',2''-{10-[2-(oxo-κO)-2-{[2-({[(12S,32S,5R,13R,16S,19S,22S)-19-(3-amino-3-oxopropyl)-16-benzyl-13-carboxy-5-hexanamido-22- [(1R)-1-hydroxyethyl]-2,4,15,18,21,24-hexaoxo-7,11- dithia-14,17,20,23-tetraaza-1(1,2),3(2,1)-dipyrrolidina- 9(1,3)-benzenacyclotetracosaphan-95- yl]methyl}sulfanyl)ethyl]amino}ethyl]-1,4,7,10- tetraazacyclododecane-1,4,7-triyl- κ4N1,N4,N7,N10}tri(acetato-κO)](177Lu)lutetium
  • [2,2',2''-{10-[2-(oxo-κO)-2-{[2-({[(12S,32S,5R,13R,16S,19S,22S)-19-(3-amino-3-oxopropyl)-16-benzyl-13-carboxy-5-hexanamido-22-[(1R)-1-hydroxyethyl]-2,4,15,18,21,24-hexaoxo-7,11-dithia-14,17,20,23-tetraaza-1(1,2),3(2,1)-dipyrrolidina-9(1,3)-benzenacyclotetracosaphan-95-yl]methyl}sulfanyl)ethyl]amino}ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triyl-κ4N1,N4,N7,N10}tri(acetato-κO)](177Lu)lutetium
  • lutetium (177Lu) rofapitide tetraxetan [INN]




UNII - T4GK6SP4E2 | UNII Search Service